Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy. According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed…
Related Posts
Traders expect 200% upside from MATIC, but does Polygon network data support that?
MATIC’s recent rally and partnerships are turning heads and on-chain activity may hint at further growth.
Ethereum dev addresses node centralization concerns in runup to the Merge
A majority of 4,653 active Ethereum nodes are being run through centralized web providers like Amazon Web Services,…
Over $3b in crypto longs at risk as Bitcoin and Ethereum hover near key levels
Over $3b in leveraged Bitcoin and Ethereum longs sit just above key support levels, with Coinglass data showing…